Skip to main content
. 2006 Jun;80(12):5697–5707. doi: 10.1128/JVI.02729-05

TABLE 2.

Survival data for BALB/c mice after WT and mutant virus infection

Virus Expt No. of survivors/total no. (MDD)a for infectious dose (PFU/mouse) of:
Virulence relative to WTb
106 105 104 103
WT
    CCHH 1 0/5 (6.6 ± 1.1) 0/5 (8.0 ± 1.7) 0/5 (9.2 ± 1.1) 5/5 (>21)
2 0/5 (6.2 ± 1.4) 0/5 (7.6 ± 1.5) 0/5 (9.0 ± 1.2) 3/5 (10.0 ± 0.0)
3 0/6 (6.7 ± 1.8) 0/5 (7.4 ± 0.5) 0/5 (8.6 ± 0.5) 1/5 (12.8 ± 4.2)
Single mutations
    CCAH 1 0/5 (5.4 ± 0.5) 0/5 (6.8 ± 0.4) 0/5 (8.0 ± 0.7) 1/5 (9.0 ± 1.2) Same
2 0/5 (5.5 ± 0.8) 1/5 (7.5 ± 0.5) 0/5 (9.2 ± 1.1) 5/5 (>21)
    CAHH 1 0/5 (8.4 ± 0.9) 1/5 (11.5 ± 6.4) 1/5 (12.8 ± 1.7) 5/5 (>21) Same
Double mutations
    CCAA 1 0/5 (6.7 ± 1.0) 0/5 (8.6 ± 1.5) 4/5 (12.0) 5/5 (>21) 10× less
    CAHA 1 0/5 (6.2 ± 0.8) 0/5 (7.0 ± 0.7) 1/5 (9.0 ± 0.0) 4/5 (10.0) Same
    CAAH 1 0/5 (7.0 ± 1.4) 0/5 (8.4 ± 1.1) 4/5 (13.0) 5/5 (>21) 10× less
    ACHA 1 0/5 (7.0 ± 1.0) 0/5 (8.0 ± 0.0) 1/5 (9.5 ± 1.7) 5/5 (>21) Same
    ACAH 1 5/5 (>21) 5/5 (>21) 5/5 (>21) 5/5 (>21) >100× less
2 6/6 (>21) 5/5 (>21) 5/5 (>21) 4/5 (12.0)
3 2/5 (9.3 ± 0.6) 3/5 (10.5 ± 3.5) 5/5 (>21) 5/5 (>21)
    AAHH 1 0/5 (8.2 ± 1.4) 0/5 (9.2 ± 1.8) 4/5 (9.0) 5/5 (>21) 10× less
Triple mutations
    CAAA 1 0/5 (7.8 ± 0.4) 0/5 (10.6 ± 1.1) 4/5 (11.0) 4/5 (11.0)
2 0/5 (7.8 ± 1.5) 0/5 (13.4 ± 3.2) 5/5 (>21) 5/5 (>21) 10× less
    ACAA 1 0/5 (7.6 ± 0.5) 3/5 (12.5 ± 0.7) 5/5 (>21) 5/5 (>21) 100× less
2 2/5 (13.0 ± 2.0) 5/5 (>21) 5/5 (>21) 5/5 (>21)
    AAHA 1 0/5 (7.6 ± 0.5) 0/5 (9.2 ± 1.6) 5/5 (>21) 5/5 (>21) 10× less
2 0/5 (7.6 ± 1.1) 0/5 (9.0 ± 1.2) 4/5 (8.0) 5/5 (>21)
    AAAH 1 6/6 (>21) 6/6 (>21) 5/5 (>21) 5/5 (>21) 100× less
Quadruple mutation
    AAAA 1 0/5 (8.0 ± 1.0) 5/5 (>21) 5/5 (>21) 5/5 (>21) 100× less
2 5/6 (11.0) 6/6 (>21) 6/6 (>21) 6/6 (>21)
a

Number of surviving mice/number of mice in group. MDD, mean day of death of mice that died within 21 days of infection.

b

Compared to WT virus.